Christophe Blanquart

Centre National de la Recherche Scientifique

Also affiliated with Inserm, Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers, Université d'Angers, Nantes Université

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

N/A

0Author DataRank · unranked

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “HRAS Q61L Mutation as a Possible Target for Non-Small Cell Lung Cancer: Case Series and Review of Literature”.

HRAS Q61L Mutation as a Possible Target for Non-Small Cell Lung Cancer: Case Series and Review of Literature

Current Oncology(2022)10.3390/curroncol29050300

N/A

0.345DataRank · unranked

9 citations

Guillaume Herbreteau, Siméon Robin, Charlotte Fenat, Jaafar Bennouna, Christophe Blanquart +3 more

Optimising response to immunotherapies in pleural mesothelioma: clinical data and alternative models for the evaluation of new strategies

Thorax(2026)10.1136/thorax-2025-223284

N/A

0DataRank · unranked

0 citations

Arnaud Scherpereel, Christophe Blanquart